Aarti Drugs Limited announced that its subsidiary, Pinnacle Life Science Private Limited, has received a “Certificate of GMP Compliance of a Manufacturer” from the Medicines and Healthcare products Regulatory Agency (UK MHRA) for its manufacturing facility located in Baddi, Himachal Pradesh. This certification confirms that Pinnacle’s facility adheres to the Good Manufacturing Practice (GMP) standards as set by the UK health authorities.
The company emphasized that no violations or contraventions have been committed, and the certification does not currently have any financial or material impact on the company. However, this recognition allows Pinnacle to export its formulations to the UK market, potentially opening new avenues for business growth.
The certification was issued on October 2, 2024, and aligns with Aarti Drugs’ compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
This update follows Aarti Drugs’ disclosure to both BSE Limited and the National Stock Exchange of India Limited, underlining its ongoing commitment to quality and regulatory compliance.
